The New GameTilray is today reportedly issuing shares to get ready for the cannabis reclassification. This is probably not to buy weed farms. The industry is plagued with over-production. The new game will be all about reducing costs by controlling strategic segments of the industry, like cannabis oil production.
Nextleaf is more than ever a seating duck. Poison pill and big players being temporary out of cash aside. Already profitable and with a unique dominating technology. Ready to be bought-out.
To my callls on this board for the new CEO to be more strategically active, she answered that Nextleaf was already providing key ingredients to the firms exporting from Canada. The coming Q results will probably show that Nextleaf is indeed gaining market shares in all jurisdictions.
All nice and good, for now. Counting beans. But nothing so far about finding a strategic partner to export our technology to the US. About finding Big Pharma partners, since our technology allows us to produce big standardized quantities reportedly like no one else.
Missing Paul.